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 Negeviruses are a group of insect-specific virus (ISV) that have been found in 20 
many arthropods. Their presence in important vector species led us to examine 21 
their interactions with arboviruses during co-infections. Wild-type negeviruses 22 
reduced the replication of several alphaviruses during co-infections in mosquito 23 
cells. Negev virus (NEGV) isolates were also used to express GFP and anti-24 
chikungunya virus (CHIKV) antibody fragments during co-infections with CHIKV. 25 
NEGV expressing anti-CHIKV antibody fragments was able to further reduce 26 
replication of CHIKV during co-infections, while reductions of CHIKV with NEGV 27 
expressing GFP were similar to titers with wild-type NEGV alone. These results are 28 
the first to show that negeviruses induce superinfection exclusion of arboviruses 29 
and to demonstrate a novel approach to deliver anti-viral antibody fragments with 30 
paratransgenic ISVs. The ability to inhibit arbovirus replication and express 31 
exogenous proteins in mosquito cells make negeviruses a promising platform for 32 
control of arthropod-borne pathogens. 33 
 34 
Importance 35 
 Negeviruses are a group of insect-specific viruses (ISVs), viruses known to 36 
only infect insects. They have been discovered over a wide geographical and species 37 
range. Their ability to infect mosquito species that transmit dangerous arboviruses 38 
makes negeviruses a candidate for a pathogen control platform. Co-infections of 39 
mosquito cells with a negevirus and an alphavirus demonstrated that negeviruses 40 
can inhibit the replication of alphaviruses. Additionally, modifying Negev virus 41 
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(NEGV) to express a fragment of an anti-CHIKV antibody further reduced the 42 
replication of CHIKV in co-infected cells. This is the first evidence to demonstrate 43 
that negeviruses can inhibit the replication of important arboviruses in mosquito 44 
cells. The ability of a modified NEGV to drive the expression of antiviral proteins 45 
also highlights a method for negeviruses to target specific pathogens and limit the 46 
incidence of vector borne diseases.  47 
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Many insect-specific viruses (ISVs) have been discovered in wild-caught and 49 
laboratory colonies of mosquitoes and in mosquito cell cultures (1). ISVs are only 50 
known to replicate in arthropods or insect cell lines. While posing no threat to 51 
human or animal health, ISVs may affect the transmission of more dangerous 52 
vector-borne pathogens. Highly insect-pathogenic ISVs have been suggested for use 53 
as biological control agents to reduce populations of vector competent mosquitoes 54 
(2-4). Several recent studies have demonstrated that ISVs may play a more direct 55 
role by inhibiting the replication of arboviruses within the insect host. The majority 56 
of these experiments have attempted to define a relationship based on 57 
superinfection exclusion, a phenomenon in which an established virus infection 58 
interferes with a secondary infection by a closely related virus. For example, insect-59 
specific flaviviruses, such as cell fusing agent virus (CFAV), Nhumirim virus (NHUV) 60 
and Palm Creek virus (PCV) have demonstrated an ability to reduce viral loads of 61 
vertebrate pathogenic flaviviruses, like West Nile virus (WNV), Zika virus (ZIKV), 62 
dengue virus (DENV), Japanese (JEV) and St. Louis encephalitis (SLEV) viruses (5-63 
10). Similarly, the insect-specific alphavirus Eilat virus (EILV) was shown to reduce 64 
or slow replication of the pathogenic alphaviruses chikungunya virus (CHIKV), 65 
Sindbis virus (SINV), eastern (EEEV), western (WEEV) and Venezuelan equine 66 
encephalitis (VEEV) viruses in cell culture or in mosquitoes (11). Less information is 67 
available about the effect of unrelated viruses during superinfection. Cell cultures 68 
chronically infected with Aedes albopictus densovirus (AalDNV) limit replication of 69 
DENV (12), cell cultures with established CFAV and Phasi Charoen-like virus (PCLV) 70 
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infections reduced ZIKV and DENV replication (13), and co-infections with Yichang 71 
virus, a mesonivirus, reduced DENV replication in cells and dissemination in 72 
mosquitoes (14). The mechanism for these reduced titers has not been elucidated, 73 
but the relationships appear to be virus specific and even host specific (5, 15, 16). 74 
The genus Negevirus is a recently discovered, unclassified group of ISVs (17). 75 
Members of this genus have been isolated from several species of hematophagous 76 
mosquitoes and sandflies, and negev-like viruses have also been found in other non-77 
vector insects (18-25). Phylogenetic studies have placed this group of viruses most 78 
closely to members of the genus Cilevirus, plant pathogens that are transmitted by 79 
mites (17, 24). These viruses have a single-stranded, positive-sense RNA genome of 80 
~9-10 kb, and contain three open reading frames (ORFs) (17). The ORFs encode for 81 
the replication machinery (ORF1), a putative glycoprotein (ORF2), and a putative 82 
membrane protein (ORF3). Electron microscopy has shown the structural proteins 83 
to be arranged in a hot air balloon morphology, a round particle with a single 84 
protrusion that is likely the glycoprotein structure (26-28). Little is known about 85 
the infectivity, transmission dynamics, and species range of negeviruses. However, 86 
they are commonly found in field collected mosquitoes (29, 30).  87 
The association of negeviruses with important vector species over a wide 88 
geographical range raises the question of possible interactions or interference of 89 
negeviruses with vertebrate pathogenic viruses. Few studies exist that demonstrate 90 
the ability of unrelated viruses to induce superinfection exclusion, but evidence for 91 
this phenomenon with negeviruses could provide a platform to control vector-borne 92 
viral diseases in many arthropod vector species. In this study, three negevirus 93 
 on M


























isolates from the Americas were assessed for superinfection exclusion in cell 94 
cultures with VEEV, CHIKV Mayaro virus (MAYV), o’nyong’nyong virus (ONNV), and 95 
Semliki Forest virus (SFV). The use of a Negev virus (NEGV) infectious clone also 96 
allowed manipulation of the virus genome to provide a greater ability to exclude 97 
superinfection with CHIKV.   98 
 99 
Results 100 
Wild-type negevirus growth curves  101 
 All wild-type negeviruses reached titers greater than 10log10 pfu/mL within 102 
48 hours when infected at a MOI of 1 (Figure 1A). NEGV and PIUV-Lutzomyia neared 103 
peak titer by 12 hours post infection (hpi), while PIUV-Culex neared peak titer at 24 104 
hpi. Infections of NEGV with MOIs of 1 and 5 produced similar growth curves 105 
(Figure 1B).  106 
 107 
Superinfection exclusion of alphaviruses with wild-type negeviruses 108 
 To determine the effect of negeviruses on the replication of alphaviruses in 109 
cell culture, negevirus isolates were co-infected with VEEV-TC83 or CHIKV isolates. 110 
NEGV was able to significantly reduce replication of VEEV-TC83, with reductions of 111 
5.5-7.0 log10 pfu/mL of VEEV at 48 hours (Figure 2A). There were no significant 112 
differences in VEEV-TC83 titers when co-infected with NEGV inoculated at MOIs of 1 113 
or 5. There were also no significant differences in VEEV-TC83 titer when NEGV 114 
inoculation preceded VEEV-TC83 inoculation by 0-, 2- or 6 hours. Co-infection with 115 
PIUV-Culex or PIUV-Lutzomyia also significantly reduced replication of VEEV-TC83 116 
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across all time points (Figure 2B-D). A similar reduction of VEEV-TC83 was 117 
observed during all negevirus co-infections, as VEEV-TC83 was reduced 4.6-7.2 118 
log10 pfu/mL at 48 hours.  119 
Co-infections with CHIKV and NEGV also resulted in significantly lower titers 120 
of CHIKV at all time points, but only reducing the titer of CHIKV by 0.65-0.93 log10 121 
pfu/mL after 48 hours (Figure 3A). Varying the MOI of NEGV and timing of CHIKV 122 
inoculation only produced differing titers of CHIKV at the 12-hour timepoint. 123 
However, titers of CHIKV during co-infection with different negeviruses varied 124 
greatly (Figure 3B, C), with the largest variance of CHIKV titers, reductions of 0.7 125 
log10, 2.4 log10 and 5.3 log10 pfu/mL, observed when inoculated 6 hours post-126 
inoculation with NEGV, -PIUV-Culex and -PIUV-Lutzomyia, respectively (Figure 3D).  127 
 NEGV and PIUV-Lutzomyia were also able to reduce replication of several 128 
other alphavirus isolates by varying amounts when infected simultaneously. Titers 129 
of VEEV-IC were reduced by 2.8-3.0 log10 pfu/mL at 48 hours post co-infection 130 
(Figure 4A). Three isolates of MAYV, Guyane, BeAn343102, and BeAr505411, were 131 
reduced by 1.9-3.2 log10 pfu/mL at 48 hours post co-infection (Figure 4B). Outputs 132 
between MAYV co-infections were similar with significant differences at 48 hours 133 
only seen between MAYV-Guyane co-infected with NEGV and PIUV-Lutzomyia, 134 
respectively. ONNV titers were reduced by 2.4-3.2 log10 pfu/mL, and SFV was 135 
reduced by 1.2-1.8 log10 pfu/mL after 48 hours (Figure 4C, D). 136 
 137 
Replication of modified NEGV isolates 138 
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The sequence for GFP was successfully cloned as both a fusion- and cleaved 139 
protein at several sites along the NEGV infectious clone (Table 1, Figure 5A). 140 
Following electroporation, viable virus was rescued from isolates with GFP inserted 141 
as a fusion- and cleaved protein on the C-terminal of ORF3, and as a cleaved protein 142 
on the C-terminal of ORF1.  143 
Further experiments used isolates with GFP added to the ORF3 (NEGV GFP-144 
fusion and NEGV GFP) and also with GFP swapped with scFv CHK265, a partial 145 
sequence for an anti-CHIKV antibody (Figure 5A). Mutated isolates were rescued 146 
and had titers ranging from 9.6-10.4 log10 pfu/mL, with similar growth curves to the 147 
wild-type NEGV (Figure 5B). Cells infected with NEGV GFP-fusion demonstrated 148 
brilliant, punctate fluorescence (Figure 5C), while cells infected with NEGV GFP 149 
(cleaved) demonstrated dull, diffuse fluorescence (Figure 5D). The number of 150 
fluorescent plaques and overall titer of NEGV isolates expressing GFP remained 151 
stable for 5 passages in C7/10 cells (Figure 5E, F). 152 
 153 
Superinfection exclusion of alphaviruses with modified NEGV 154 
 NEGV isolates expressing GFP or scFv-CHK265 were used to infect cells for 155 
co-infection with VEEV-TC83 or CHIKV. The results for co-infections with VEEV-156 
TC83 were similar to the reduction in titer seen with wild-type viruses. At the 48-157 
hour timepoint, VEEV-TC83 was reduced by 4.5-5.5 log10 pfu/mL when co-infected 158 
with NEGV isolates (Figure 6A), 4.6-5.8 log10 pfu/mL when infected 2 hours post 159 
NEGV isolates (Figure 6B), and 5.6-6.9 log10 pfu/mL when infected 6 hours post 160 
NEGV isolates (Figure 6C). When infected simultaneously with CHIKV, titers were 161 
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reduced by 0.7-1.1 log10 pfu/mL during co-infections of NEGV expressing GFP, and 162 
by 2.9-3.8 log10 pfu/mL during co-infections of NEGV expressing scFv-CHK265 at the 163 
48-hour timepoint (Figure 7A). When inoculated 2 hours post NEGV infection, the 164 
titer of CHIKV after 48 hours was reduced 0.7-0.9 log10 pfu/mL with NEGV 165 
expressing GFP and 3.7-4.5 log10 pfu/mL with NEGV expressing scFv-CHK265 166 
(Figure 7B). Delaying CHIKV infection 6 hours post NEGV resulted in reductions of 167 
1.2-1.9 log10 pfu/mL and 5.2-5.7 log10 pfu/mL after 48 hours of co-infection with 168 
NEGV expressing GFP and scFv-CHK265, respectively (Figure 7C). 169 
 170 
Discussion 171 
 The microbiome of arthropod vectors is known to influence host-pathogen 172 
interactions (31-33). The precise mechanisms of pathogen inhibition are unknown, 173 
but there is increasing evidence that interference from ISVs is one mechanism (5-7, 174 
10). Interactions between related viruses has led to the theory of superinfection 175 
exclusion, in which an established infection interferes with or inhibits a secondary 176 
infection by a closely related virus. For example, a CFAV mosquito isolate reduced 177 
the replication of DENV and ZIKV during co-infections in mosquitoes and mosquito 178 
cells (5).  179 
 To investigate if superinfection exclusion occurred with other virus 180 
combinations, pathogenic alphaviruses and negeviruses were used in co-infection 181 
experiments. Titers of multiple VEEV isolates and MAYV isolates were consistently 182 
reduced during co-infection experiments with negeviruses. Reductions varied 183 
during CHIKV-negevirus co-infections. These results provide further evidence that 184 
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superinfection exclusion of alphaviruses is pathogen specific, but differ from a 185 
previous report demonstrating no reduction in titer of VEEV TC-83 and a significant 186 
reduction of wild-type VEEV-IC (strain 3908) after 48 hours when co-infected with 187 
EILV, an alphavirus ISV (11). However, the potential for superinfection exclusion of 188 
pathogens is different for each ISV, despite their relatedness. These differences have 189 
been demonstrated among several insect-specific flaviviruses, Nhumirim virus 190 
(NHUV) and Palm Creek virus (PCV) were capable of superinfection exclusion; CFAV 191 
gave varying results; and Culex flavivirus (CxFV) did not reduce titers of pathogenic 192 
arboviruses (5-10, 15, 16, 34-37). In our experiments with negeviruses, PIUV 193 
isolates were more capable than NEGV at inhibiting important arboviruses.  194 
While ISVs show promising results to block arbovirus replication in 195 
mosquito vectors, their unknown mechanism of action may limit their use against a 196 
wide range of pathogens, but paratransgenic ISVs could be used to provide antiviral 197 
molecules that specifically interfere with pathogen transmission (38). To this end, 198 
we used an infectious clone of NEGV to deliver a fragment of an antibody known to 199 
neutralize CHIKV (39). A scFv consists of the variable regions of the heavy and light 200 
chains of an antibody, joined by a soluble linker. These antibody fragments can 201 
possess the neutralizing qualities of their full-size versions in only ~27kDa. Co-202 
infections with scFv-expressing NEGV isolates greatly reduced titers of CHIKV, 203 
whereas co-infections with control NEGV isolates expressing GFP or wild-type NEGV 204 
only modestly reduced CHIKV titers. The use of parastransgenic NEGV expressing 205 
scFvs demonstrates a novel approach to disrupt pathogen infection in mosquitoes. 206 
This method adapts two existing techniques for pathogen control: Wolbachia 207 
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infected mosquitoes and the CRISPR-Cas-aided integration of scFv sequences into 208 
the mosquito genome. Wolbachia is a ubiquitous species of bacteria found in many 209 
insects that has been shown to block replication of some viral pathogens in cell 210 
cultures and mosquitoes. The use of Wolbachia-infected vectors has been widely 211 
adapted to curb mosquito-borne viral diseases, propelled by its natural ability to 212 
colonize mosquitoes (40). Negeviruses also possess this attribute, having been 213 
discovered in numerous mosquito species on 6 continents, along with sandflies and 214 
other diverse insect species (20-23, 25). Insertion of gene-editing scFv sequences 215 
into mosquito genomes has also been used to prevent Plasmodium and DENV 216 
infection (41, 42). By using CRISPR-Cas9 to insert a scFv targeting Plasmodium, 217 
infection was blocked in Anopheles mosquitoes, and gene drive ensured the 218 
production of the scFv in the offspring. In this study, we used scFv expression 219 
strategy by cloning an anti-CHIKV scFv into the NEGV genome. Using NEGV as a 220 
vehicle for paratransgensis is advantageous, because an isolate can infect multiple 221 
host species, and it is suspected to be vertically transmitted in mosquitoes and in 222 
theory could become established in multiple generations of the infected host species 223 
(17, 22, 43).  224 
Modifications to certain parts of the NEGV genome were tolerated as both 225 
cleaved and fusion proteins. Expression of extraneous proteins in viruses is 226 
common with 2A sequences to produce separate proteins or under a separate 227 
subgenomic promoter (44, 45). However, extraneous proteins expressed as a fusion 228 
with a structural virus protein is uncommon. ORF3 is ~25kDa and is suspected to be 229 
the membrane protein, the dominant structural protein; and ORF2 is ~40kDa and is 230 
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the putative glycoprotein predicted to form a bud projecting from one end of the 231 
virion (26). The viability of the NEGV isolates with GFP- or scFv-fusion at ORF3 232 
isolates was surprising because these inserts double the size of the membrane 233 
protein, which must interact with itself and ultimately support the projection of the 234 
glycoprotein. The modifications to ORF2 resulting in non-viable virus are not 235 
surprising as the glycoprotein is suggested to be important for cell attachment and 236 
entry (26). GFP preceded by a 2A sequence was also successfully cloned onto the C-237 
terminal of ORF1. As 2A allows for separation of the two proteins, this insertion only 238 
added 17 residues to a ~268kDa protein. However, ORF1 will likely be expressed at 239 
lower levels compared to ORF3. By using NEGV to express anti-CHIKV scFvs, the 240 
cleaved and fused inserts may provide distinct advantages. Cleaved scFvs are free to 241 
be transported around the cell, accessing many different locations where they may 242 
encounter CHIKV proteins. In contrast, fused proteins are bound to the membrane 243 
protein of NEGV and are limited to compartments of the cell where NEGV proteins 244 
are expressed, and virions are assembled. In theory, increasing the concentration of 245 
the scFvs in specific areas of the cell, should inhibit CHIKV virion assembly and 246 
egression. By using both cleaved and fused NEGV isolates, the scFv sequence can 247 
also be easily replaced to target a new pathogen, adding to the versatility of this 248 
technique.  249 
 The current experiments demonstrate the ability of some negeviruses, both 250 
wild-type and paratransgenic isolates, to inhibit the replication in mosquito cells 251 
with co-infected arboviruses. The next question is whether genetically altered 252 
negeviruses will survive and replicate in live mosquitoes; and if so, will they be 253 
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vertically transmitted or transovarially transmitted in the insects? This will be our 254 
next area of investigation. If successful, then the use of paratransgenic negeviruses 255 
could be another novel method to alter the vector competence of mosquitoes for 256 
selected arboviruses. 257 
 258 
Materials and Methods 259 
Cell culture and viruses 260 
 Aedes albopictus (C7/10) cells (46) were obtained from the World Reference 261 
Center for Emerging Viruses and Arboviruses (WRCEVA). African green monkey 262 
kidney (Vero E6) cells were obtained from the American Type Culture Collection 263 
(ATCC). C7/10 cells were maintained in Dulbecco’s minimal essential medium 264 
(DMEM) supplemented with 10% fetal bovine serum (FBS), 1% minimal essential 265 
medium non-essential amino acids, 1% tryptose phosphate broth and 0.05 mg/mL 266 
gentamycin in a 30°C incubator with 5% CO2. Vero cells were maintained in DMEM 267 
supplemented with 10% FBS and 0.05 mg/mL gentamycin in a 37°C incubator with 268 
5% CO2. 269 
 NEGV was rescued in C7/10 cells from an infectious clone as previously 270 
described and without further passage (47). The sequence was derived from NEGV 271 
strain M30957 isolated from a pool of Culex coronator mosquitoes collected in 272 
Harris County, Texas, USA in 2008 (17). Piura virus (PIUV) strain EVG 7-47 (PIUV-273 
Culex) isolated from a pool of Culex nigripalpus mosquitoes from Everglades 274 
National Park, Florida, USA in 2013 (22). PIUV EVG 7-47 was passaged four times in 275 
C6/36 cells and obtained from the WRCEVA. PIUV strain CO R 10 (PIUV-Lutzomyia) 276 
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was isolated from a pool of Lutzomyia evansi sandflies caught in Ovejas, Sucre, 277 
Colombia in 2013 (22). The isolate PIUV CO R 10 was passaged twice in C6/36 cells 278 
and also obtained from the WRCEVA. CHIKV isolate 181/25 (48) was rescued in 279 
Vero cells from an infectious clone as previously described (49). Rescued CHIKV 280 
181/25 was subsequently passaged once in C7/10 cells and once in Vero cells. 281 
Venezuelan equine encephalitis virus (VEEV) vaccine strain, TC-83 (50), was 282 
rescued in baby hamster kidney (BHK) cells from an infectious clone without 283 
further passage. VEEV isolate P676 (VEEV-IC), and SFV isolate A774/C2/A were 284 
attained from Public Health England and passaged once in Vero cells. ONNV isolate 285 
UgMP30, and Mayaro virus (MAYV) isolates Guyane, BeAn344102, and BeAr505411 286 
were attained from BEI Resources and passaged once in Vero cells.   287 
 288 
Cloning NEGV for exogenous gene expression 289 
 The NEGV infectious clone was used as the backbone to express exogenous 290 
genes. Green fluorescent protein (GFP; 717bp) was inserted along several sites of 291 
the NEGV genome and the single chain variable fragment (scFv) of anti-CHIKV 292 
neutralizing antibody CHK265 (771bp including linkers) (39) was inserted on the C-293 
terminal of ORF3 as either a fusion protein, or with a 2A sequence 294 
(EGRGSLLTCGDVEENPGP) (Figure 1A). The cloned scFv CHK265 sequence 295 
contained a N-terminal linker (LAAQPAMA) for articulation from the viral ORF3 296 
protein, and a domain linker ((G4S)4) between the variable heavy (VH) and variable 297 
light (VL) domains (Integrative DNA Technologies) (Figure 1B). Cloning was 298 
performed using In-Fusion HD Cloning Kit (Takara Bio) as per the manufacturer’s 299 
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protocol. Correct insertion was confirmed by sequencing. Infectious clones of NEGV 300 
containing exogenous genes were rescued in C7/10 cells as previously described 301 
and without further passage (47). Passaging of NEGV isolates expressing GFP was 302 
performed by inoculating C7/10 cells with a MOI of 1 and collecting media 303 
supernatant at 48 hours post infection. 304 
 305 
Virus growth curves 306 
 Negevirus and alphavirus growth curves were done in C7/10 cells 307 
maintained at 30°C and 5% CO2. Negeviruses were inoculated at a multiplicity of 308 
infection (MOI) of 1 or 5. Alphaviruses were inoculated at a MOI of 0.1. Virus was 309 
added to the cells which were incubated at 30°C for one hour. Inoculum was 310 
removed, cells were washed with PBS, and fresh media was added to the wells. Cells 311 
were incubated in a 30°C incubator with 5% CO2. Samples were collected in 312 
triplicate at 2-, 6-, 12-, 24- and 48-hours post infection (hpi). Samples were clarified 313 
by centrifugation at 1962 x g for 5 minutes. Supernatant was removed and stored at 314 
-80°C until used for plaque assays.  Negevirus titers were determined by plaque 315 
assay in C7/10 cells as previously described (47). Alphavirus titers were 316 
determined by standard plaque assay in Vero cells. 317 
 318 
Negevirus-alphavirus co-infections 319 
 C7/10 cells were inoculated with negevirus isolates at a MOI of 1 or 5 to 320 
establish infection in a high proportion of cells. The cells were also inoculated with 321 
an alphavirus at a MOI of 0.1 at 0, 2, or 6 hours post negevirus infection. Media was 322 
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removed after 1 hour of simultaneous incubation with negevirus and alphavirus 323 
inocula. Cells were then washed with PBS, and fresh medium was added to the wells. 324 
Cells were held in a 30°C incubator with 5% CO2. Samples were collected in 325 
triplicate at 12-, 24- and 48-hours, or 24- and 48-hours post alphavirus infection. 326 
Samples were clarified by centrifugation at 1962 x g for 5 minutes. Supernatant was 327 
removed and stored at -80°C until used for plaque assays. Alphavirus titers were 328 
determined by standard plaque assay in Vero cells. 329 
 330 
Statistical analysis 331 
 Differences in virus growth curves were determined by two-way ANOVA 332 
followed by Tukey’s test. Comparison of NEGV growth curves with different MOIs 333 
was determined by multiple t tests followed by Holm-Sidak method. All statistical 334 
tests were performed using GraphPad Prism 6.0. 335 
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Figure legends 547 
Figure 1. Growth curve for wild-type negeviruses. A) The titer of each virus, Negev 548 
virus (NEGV), Piura virus-Culex (PIUV-Culex) and Piura virus-Lutzomyia (PIUV-549 
Lutzomyia) at different time points following infection at MOI of 1 in C7/10 cells. B) 550 
Growth curve of NEGV with MOI of 1 and 5 in C7/10 cells. All points represent mean 551 
of n=3, ± SD. Letters indicate significant differences (p < 0.0001). 552 
 553 
Figure 2. Growth curves of VEEV-TC83 in C7/10 cells during co-infections with wild-554 
type negeviruses. A) Growth curves of VEEV-TC83 when inoculated on cells at 0-, 2- 555 
and 6 hours post NEGV infections. NEGV was inoculated at MOI 1 or 5. B) Growth 556 
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curves of VEEV-TC83 when inoculated on cells at 0 hours post negevirus infection, 557 
C) 2 hours post negevirus infection, and D) 6 hours post negevirus infection. 558 
Negeviruses were inoculated at MOI of 1 (B-D). VEEV-TC83 was inoculated at a MOI 559 
of 0.1 in all conditions. All points represent mean of n=3, ± SD. Letters indicate 560 
significant differences (p < 0.0001). 561 
 562 
Figure 3. Growth curves of CHIKV in C7/10 cells during co-infections with wild-type 563 
negeviruses. A) Growth curves of CHIKV when inoculated on cells at 0-, 2- and 6 564 
hours post NEGV infections. NEGV was inoculated at MOI 1 or 5. B) Growth curves of 565 
CHIKV when inoculated on cells at 0 hours post negevirus infection, C) 2 hours post 566 
negevirus infection, and D) 6 hours post negevirus infection. Negeviruses were 567 
inoculated at MOI of 1 (B-D). CHIKV was inoculated at a MOI of 0.1 in all conditions. 568 
All points represent mean of n=3, ± SD. Letters indicate significant differences (p < 569 
0.0001). 570 
 571 
Figure 4. Growth curves of VEEV-IC, MAYV isolates, ONNV, and SFV in C7/10 cells 572 
during co-infections with wild-type negeviruses. A) Growth curves of VEEV-IC when 573 
inoculated on cells at 0 hours post negevirus infections. B) Growth curves of MAYV-574 
Guyane, MAYV-BeAn343102, and MAYV-BeAr505411 when inoculated on cells at 0 575 
hours post negevirus infection. C) Growth curves of ONNV when inoculated on cells 576 
at 0 hours post negevirus infection. D) Growth curves of SFV when inoculated on 577 
cells at 0 hours post negevirus infection. Negeviruses were inoculated at MOI of 1 in 578 
all conditions. Alphaviruses were inoculated at a MOI of 0.1 in all conditions. All 579 
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points represent mean of n=3, ± SD. Letters indicate significant differences (p < 580 
0.0001). 581 
 582 
Figure 5. Rescued paratransgenic NEGV infectious clones. A) Schematic of NEGV 583 
genomes for wild-type, and GFP-expressing viruses. NEGV GFP-fusion added the 584 
GFP sequence onto ORF3 and NEGV GFP separated the ORF3 and GFP with a 2A 585 
sequence to produce the proteins separately. GFP was replaced by scFv-CHK265 for 586 
NEGV scFv-CHK265-fusion and NEGV scFv-CHK265. B) Growth curves of NEGV 587 
wild-type and NEGV mutants expressing GFP or scFv-CHK265. All points represent 588 
mean of n=3, ± SD. Letters indicate significant differences (p < 0.0001). C) 589 
Fluorescent microscopy of C7/10 cells infected with NEGV GFP-fusion. Cells 590 
demonstrate brilliant, punctate fluorescence. D) Fluorescent microscopy of C7/10 591 
cells infected with NEGV GFP. Cells demonstrate dull, diffuse fluorescence. E) The 592 
ratio of plaques to fluorescent plaques over 5 passages in C7/10 cells with NEGV 593 
GFP-fusion and NEGV GFP. All points represent mean of n=3, ± SD. F) Titer of NEGV 594 
GFP-fusion and NEGV GFP during 5 passages in C7/10 cells. All points represent 595 
mean of n=3, ± SD. All NEGV isolates were inoculated at MOI of 1. 596 
 597 
Figure 6. Growth curves of VEEV-TC83 during co-infections with paratransgenic 598 
NEGV. Growth curves of VEEV-TC83 when inoculated on cells at A) 0 hours post 599 
NEGV infection, B) 2 hours post NEGV infection, and C) 6 hours post NEGV infection. 600 
All NEGV isolates were inoculated at MOI of 1. VEEV-TC83 was inoculated at a MOI 601 
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of 0.1 in all conditions. All points represent mean of n=3, ± SD. Letters indicate 602 
significant differences (p < 0.0001). 603 
 604 
Figure 7. Growth curves of CHIKV during co-infections with paratransgenic NEGV. 605 
Growth curves of CHIKV when inoculated on cells at A) 0 hours post NEGV infection, 606 
B) 2 hours post NEGV infection, and C) 6 hours post NEGV infection. All NEGV 607 
isolates were inoculated at MOI of 1. CHIKV was inoculated at a MOI of 0.1 in all 608 
conditions. All points represent mean of n=3, ± SD. Letters indicate significant 609 
differences (p < 0.0001).  610 
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Table 1. Rescue and passage of NEGV infectious clones with GFP inserted at different 612 
sites of the genome. Transcribed RNA was electroporated for P0 stock and 613 
supernatant was collected to generate P1 stock. 614 
Insertion site GFP expression P0 GFP expression P1 CPE 
ORF1-2A-GFP + + + 
GFP-ORF2 + - - 
ORF2-GFP + - - 
ORF2-2A-GFP + - - 
GFP-ORF3 + - - 
ORF3-GFP + + + 
ORF3-2A-GFP + + + 
  615 
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